Aimmune Submits Marketing Authorization Application to European Medicines Agency for AR101 for Peanut Allergy

131

BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Submits Marketing Authorization Application to European Medicines Agency for AR101 for Peanut Allergy…..

 

 

 

http://www.businesswire.com/news/home/20190628005065/en/Aimmune-Submits-Marketing-Authorization-Application-European-Medicines